| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-18 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-18 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-16 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-13 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-12 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-11 |